Investor Overview

Corporate Profile

Accuray develops, manufactures and sells radiation oncology systems that make cancer treatments shorter, safer, smarter and more effective. Accuray provides treatment delivery technologies that set the industry standard for precision and cover the full range of radiation therapy and radiosurgery treatments, as well as fully integrated software solutions that drive faster, smarter treatment planning.

Press Releases

July 25, 2018 at 7:30 AM EDT

Summary Toggle Addenbrooke's Hospital is First in the UK to Treat Cancer Patients with Accuray Radixact® System

Internationally Renowned Centre in Cambridge, England is First NHS Hospital to Install the Innovative Radiation Therapy System SUNNYVALE, Calif. , July 25, 2018 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the Addenbrooke's Hospital clinical team has treated the first
July 19, 2018 at 4:03 PM EDT

Summary Toggle Joseph E. Whitters Appointed to Accuray Board of Directors

SUNNYVALE, Calif. , July 19, 2018 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today the appointment of Joseph E. Whitters to the company's Board of Directors, effective as of July 16, 2018 . In addition, he will serve on the Board's Audit Committee. With Mr.

View All

Events

View All

Annual Reports

Filing date	Form
Aug 25, 2017	10-K
Aug 24, 2016	10-K

View All

Investor Relations

Innovating patient-first cancer treatments.

Investor Overview

Corporate Profile

Q4 2018 Accuray Incorporated Earnings Conference Call

Investor Relations

Innovating patient-first cancer treatments.

Investor Overview

Corporate Profile

Q4 2018 Accuray Incorporated Earnings Conference Call

Connect with us on social media.